Clinical Study Human & experimental toxicology 2020

Derangement of PaCO(2) requires physician attention in acute carbon monoxide poisoning.

Moon JM, Chun BJ, Cho YS — Human & experimental toxicology, 2020

View Original on PubMed PMID 31928235

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers aimed to describe the prevalence of derangement of the partial pressure of arterial carbon dioxide (PaCO₂).

What They Found

The provided abstract is incomplete and does not contain the study's findings or specific numerical results. Therefore, the prevalence and characteristics of PaCO₂ derangement observed in this study cannot be reported.

Canadian Relevance

This clinical study does not have a direct Canadian connection.

Study Limitations

The specific limitations of this study are not detailed within the provided abstract.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Clinical Study
Category	Uncategorised
Source	Pubmed
PubMed ID	31928235
Year Published	2020
Journal	Human & experimental toxicology
MeSH Terms	Adult; Aged; Blood Gas Analysis; Carbon Dioxide; Carbon Monoxide Poisoning; Female; Heart Arrest; Heart Injuries; Hospitalization; Humans; Hyperbaric Oxygenation; Hypocapnia; Male; Middle Aged; Partial Pressure

Related Research

J Int Med Res | 2004 RCT

Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome

Kiralp MZ, Yildiz S, Vural D, et al.

Undersea Hyperb Med | 2013 Clinical Study

The efficacy of hyperbaric oxygen therapy in the management of chronic fatigue syndrome

Akarsu S, Tekin L, Ay H, et al.

Int J Med Sci | 2024 Retrospective Study

The effectiveness of hyperbaric oxygen treatment in patients with complex regional pain syndrome: a retrospective case series

Hajek M, Hadanny A, Engel-Yeger B, et al.

BMJ Open | 2024 RCT

Protocol for a multicentric, double-blind, randomised controlled trial of HBOT versus sham for vaso-occlusive crisis in sickle cell disease (HBOT-SCD study)

Stirnemann J, Serratrice J, Mann T, et al.

Undersea Hyperb Med | 2024 RCT

Outcomes after pancreaticoduodenectomy with or without preoperative hyperbaric oxygen therapy

Jacoby H, Camporesi EM, Ross SB, et al.

See all Uncategorised research

View on PubMed Back to Research Library

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: June 8, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology